Allergy and Immunology · Royal Oak, MI
NPI
1033134317
Since 2006
Specialty
Allergy and Immunology
Code 207K00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
3600 W 13 Mile Rd
Royal Oak, MI, 48073
Phone (248) 549-0777
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.2M
59,216 services
Medicare patients, 2024
654
Average age 73
Drug cost, 2024
$2.0M
6,533 prescriptions
Company payments, 2025
$2,140
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mohamad Y Tawila was code J2357 (injection, omalizumab, 5 mg), 17,266 times for 35 patients. In total Mohamad Y Tawila billed 59,216 services in 33 codes, and Medicare paid $1.2M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J2357 Injection, omalizumab, 5 mg | Office | 17,266 | 35 | $29.64 | $512K |
| 95004 Test - Miscellaneous | Office | 8,889 | 123 | $3.01 | $27K |
| 95165 Treatment - Miscellaneous | Office | 6,212 | 215 | $10.83 | $67K |
| 95117 Treatment - Miscellaneous | Office | 3,845 | 197 | $8.73 | $34K |
| 95024 Test - Miscellaneous | Office | 2,461 | 114 | $6.37 | $16K |
| 95044 Test - Miscellaneous | Office | 1,498 | 21 | $4.08 | $6,106 |
| 99213 Office E&M - Established | Office | 1,363 | 555 | $65.95 | $90K |
| 95115 Treatment - Miscellaneous | Office | 902 | 50 | $7.16 | $6,460 |
| 96372 Injection Administration | Office | 857 | 65 | $10.41 | $8,921 |
| 94060 Pulmonary Function Testing | Office | 739 | 404 | $28.54 | $21K |
| 94726 Pulmonary Function Testing | Office | 173 | 169 | $41.01 | $7,094 |
| 94729 Pulmonary Function Testing | Office | 165 | 161 | $41.91 | $6,916 |
| 99204 Office E&M - New | Office | 129 | 129 | $127.39 | $16K |
| 95018 Test - Miscellaneous | Office | 123 | 13 | $14.89 | $1,832 |
| G0008 Administration of influenza virus vaccine | Office | 75 | 73 | $32.71 | $2,453 |
By year: 2022 $1.1M for 52,376 services; 2023 $1.3M for 60,180 services; 2024 $1.2M for 59,216 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mohamad Y Tawila prescribed most often to Medicare patients was Montelukast Sodium, with 1,479 prescriptions and refills. In total Mohamad Y Tawila wrote 6,533 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Montelukast Sodium Generic | 1,479 | 2,390 | 427 | $15K |
| Azelastine Hcl Generic | 658 | 964 | 235 | $20K |
| Fluticasone Propionate Generic | 508 | 733 | 173 | $6,808 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 458 | 481 | 179 | $16K |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 241 | 279 | 83 | $36K |
| Famotidine Generic | 216 | 295 | 72 | $2,131 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 212 | 251 | 67 | $154K |
| Prednisone Generic | 184 | 186 | 135 | $558 |
| Breo Ellipta Fluticasone/Vilanterol | 150 | 182 | 39 | $69K |
| Levocetirizine Dihydrochloride Generic | 132 | 196 | 37 | $1,364 |
| Symbicort Budesonide/Formoterol Fumarate | 130 | 156 | 41 | $34K |
| Dupixent Syringe Dupilumab | 130 | 130 | 18 | $471K |
| Ventolin Hfa Albuterol Sulfate | 129 | 139 | 55 | $8,138 |
| Triamcinolone Acetonide Generic | 126 | 148 | 64 | $933 |
| Ipratropium Bromide Generic | 104 | 156 | 42 | $3,995 |
Brand drugs: 2,016 claims; generic drugs: 4,517 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mohamad Y Tawila $2,140 ($2,140 in general payments such as food, travel and fees) from 19 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $590.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 21 | $590 |
| Amgen Inc. AMGN | 22 | $292 |
| GlaxoSmithKline, LLC. GSK | 19 | $241 |
| Optinose US, Inc. | 9 | $239 |
| Genzyme Corporation SNY | 6 | $127 |
| CSL Behring CSL.AX | 4 | $98.88 |
| Novartis Pharmaceuticals Corporation NVS | 5 | $98.09 |
| LEO Pharma Inc. | 4 | $77.51 |
| Regeneron Healthcare Solutions, Inc. REGN | 3 | $76.48 |
| Galderma Laboratories, L.P. GALD.SW | 3 | $55.56 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.